Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT01630668
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- Micropharma Limited
- Registry
-
NCT01630668
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01630668. Randomized; double masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule
- Condition
- Hypercholesterolemia
- Intervention (Dietary supplement)
- One-a-Day L. reuteri NCIMB 30242 supplement capsule
- Intervention (Dietary supplement)
- One-a-Day placebo capsule
- Lead sponsor
- Micropharma Limited
Record details
- Record id
cardio:ct-nct01630668- Content hash
c884cf25b943cb2d77e8d9cfd3b1e6f9ef3c516d4de3af3a69feab5bf8c0b344